Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  United Therapeutics Corporation    UTHR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. engages in the development and commercialization of innovative products for patients with chronic and life-threatening diseases.

It markets and sells commercial therapies to treat pulmonary arterial hypertension, high-risk neuroblastoma.

It is also involved in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies.

The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 750 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,466100%1,599100% +9.08%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States1,35392.3%1,46291.4% +8.05%
Rest of World112.767.7%136.908.6% +21.41%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA621996Chairman & Chief Executive Officer
Michael Benkowitz452011President & Chief Operating Officer
James Christopher Edgemond492013CFO, Treasurer & Principal Accounting Officer
Raymond C. Kurzweil, PhD692002Independent Director
Louis Wade Sullivan, MD832013Independent Director
Raymond Allen Dwek752002Non-Independent Director
Christopher Patusky532002Vice Chairman
Christopher Causey, MBA542003Independent Director
Richard Giltner532009Independent Director
Tommy George Thompson752010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 69,830,269 42,480,972 60.8% 26,619,216 38.1% 60.8%
Shareholders
NameEquities%
Fidelity Management & Research Co. 4,198,790 9.72%
BlackRock Fund Advisors 4,141,187 9.58%
The Vanguard Group, Inc. 3,497,576 8.09%
AQR Capital Management LLC 2,180,000 5.05%
SSgA Funds Management, Inc. 2,092,131 4.84%
Palo Alto Investors LLC 1,762,650 4.08%
Renaissance Technologies LLC 1,273,000 2.95%
Acadian Asset Management LLC 1,094,946 2.53%
Goldman Sachs & Co. LLC (Private Banking) 1,051,604 2.43%
Schroder Investment Management Ltd. 985,996 2.28%
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
UNITED THERAPEUTICS CORPORATION-5.03%5 889
CELLTRION, INC.--.--%23 699
IQVIA HOLDINGS INC32.70%21 261
INCYTE CORPORATION-3.68%20 703
LONZA GROUP57.44%20 102
ALNYLAM PHARMACEUTICALS, INC.249.60%12 278
NEKTAR THERAPEUTICS339.85%8 917
ALKERMES PLC-4.86%8 035
SEATTLE GENETICS, INC.12.30%8 018
QIAGEN NV7.36%7 398
SAGE THERAPEUTICS INC227.73%6 760
IONIS PHARMACEUTICALS INC14.15%6 662
EXACT SCIENCES CORPORATION302.92%6 212
ICON PLC47.79%6 154
PRA HEALTH SCIENCES INC48.04%5 528
CHARLES RIVER LABORATORIES INTL. INC36.29%5 020
BIO-TECHNE CORP25.22%4 787
GALAPAGOS24.78%4 379
INC RESEARCH HOLDINGS INC-24.81%4 315
PUMA BIOTECHNOLOGY INC242.02%3 948
BB BIOTECH AG19.33%3 732
Connections : United Therapeutics Corpor
Thompson Holdings, Inc.
FatKat, Inc.
X PRIZE Foundation
Patusky Associates LLC
Singularity Education Group
Kurzweil Technologies, Inc.
Medical Learning Co., Inc.
The Sullivan Alliance
Morehouse School of Medicine
Lung Biotechnology PBC
Public Broadcasting Atlanta
Causey Consortium
America's Public Television Stations
Vital Decisions LLC
Accordia Global Health Foundation
Synthetic Genomics, Inc.
Cleveland HeartLab, Inc.
State Bar of Wisconsin
Armada Media Corp.
Oxford Glycobiology Institute
Medical Missions For Children, Inc.
University of Oxford
The District of Columbia Bar
Slater Run Vineyards LLC
MTS Health Investors LLC
© 2017 People , Fundamentals and Ownership